Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jan 2024. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5289783012 | Product containing precisely dexamethasone 1 milligram/1 milliliter and neomycin (as neomycin sulfate) 3500 unit/1 milliliter and polymyxin B sulfate 6000 unit/1 milliliter conventional release suspension for eye drops (clinical drug) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 5348090015 | Dexamethasone 1 mg/mL and neomycin (as neomycin sulfate) 3500 unit/mL and polymyxin B sulfate 6000 unit/mL eye drops suspension | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely dexamethasone 1 milligram/1 milliliter and neomycin (as neomycin sulfate) 3500 unit/1 milliliter and polymyxin B sulfate 6000 unit/1 milliliter conventional release suspension for eye drops (clinical drug) | Has manufactured dose form | Eye drops suspension | true | Inferred relationship | Some | ||
| Product containing precisely dexamethasone 1 milligram/1 milliliter and neomycin (as neomycin sulfate) 3500 unit/1 milliliter and polymyxin B sulfate 6000 unit/1 milliliter conventional release suspension for eye drops (clinical drug) | Plays role | Antibacterial therapeutic role (role) | false | Inferred relationship | Some | ||
| Product containing precisely dexamethasone 1 milligram/1 milliliter and neomycin (as neomycin sulfate) 3500 unit/1 milliliter and polymyxin B sulfate 6000 unit/1 milliliter conventional release suspension for eye drops (clinical drug) | Has precise active ingredient | Dexamethasone (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely dexamethasone 1 milligram/1 milliliter and neomycin (as neomycin sulfate) 3500 unit/1 milliliter and polymyxin B sulfate 6000 unit/1 milliliter conventional release suspension for eye drops (clinical drug) | Has basis of strength substance (attribute) | Dexamethasone (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely dexamethasone 1 milligram/1 milliliter and neomycin (as neomycin sulfate) 3500 unit/1 milliliter and polymyxin B sulfate 6000 unit/1 milliliter conventional release suspension for eye drops (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Product containing precisely dexamethasone 1 milligram/1 milliliter and neomycin (as neomycin sulfate) 3500 unit/1 milliliter and polymyxin B sulfate 6000 unit/1 milliliter conventional release suspension for eye drops (clinical drug) | Has concentration strength denominator unit | mL | true | Inferred relationship | Some | 1 | |
| Product containing precisely dexamethasone 1 milligram/1 milliliter and neomycin (as neomycin sulfate) 3500 unit/1 milliliter and polymyxin B sulfate 6000 unit/1 milliliter conventional release suspension for eye drops (clinical drug) | Has precise active ingredient | Polymyxin B (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely dexamethasone 1 milligram/1 milliliter and neomycin (as neomycin sulfate) 3500 unit/1 milliliter and polymyxin B sulfate 6000 unit/1 milliliter conventional release suspension for eye drops (clinical drug) | Has basis of strength substance (attribute) | Polymyxin B (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely dexamethasone 1 milligram/1 milliliter and neomycin (as neomycin sulfate) 3500 unit/1 milliliter and polymyxin B sulfate 6000 unit/1 milliliter conventional release suspension for eye drops (clinical drug) | Has concentration strength numerator unit | IU | true | Inferred relationship | Some | 2 | |
| Product containing precisely dexamethasone 1 milligram/1 milliliter and neomycin (as neomycin sulfate) 3500 unit/1 milliliter and polymyxin B sulfate 6000 unit/1 milliliter conventional release suspension for eye drops (clinical drug) | Has concentration strength denominator unit | mL | true | Inferred relationship | Some | 2 | |
| Product containing precisely dexamethasone 1 milligram/1 milliliter and neomycin (as neomycin sulfate) 3500 unit/1 milliliter and polymyxin B sulfate 6000 unit/1 milliliter conventional release suspension for eye drops (clinical drug) | Has precise active ingredient | Neomycin sulfate | true | Inferred relationship | Some | 3 | |
| Product containing precisely dexamethasone 1 milligram/1 milliliter and neomycin (as neomycin sulfate) 3500 unit/1 milliliter and polymyxin B sulfate 6000 unit/1 milliliter conventional release suspension for eye drops (clinical drug) | Has basis of strength substance (attribute) | Neomycin (substance) | true | Inferred relationship | Some | 3 | |
| Product containing precisely dexamethasone 1 milligram/1 milliliter and neomycin (as neomycin sulfate) 3500 unit/1 milliliter and polymyxin B sulfate 6000 unit/1 milliliter conventional release suspension for eye drops (clinical drug) | Has concentration strength numerator unit | IU | true | Inferred relationship | Some | 3 | |
| Product containing precisely dexamethasone 1 milligram/1 milliliter and neomycin (as neomycin sulfate) 3500 unit/1 milliliter and polymyxin B sulfate 6000 unit/1 milliliter conventional release suspension for eye drops (clinical drug) | Has concentration strength denominator unit | mL | true | Inferred relationship | Some | 3 | |
| Product containing precisely dexamethasone 1 milligram/1 milliliter and neomycin (as neomycin sulfate) 3500 unit/1 milliliter and polymyxin B sulfate 6000 unit/1 milliliter conventional release suspension for eye drops (clinical drug) | Is a | Product containing only dexamethasone and neomycin and polymyxin B in ocular dose form (medicinal product form) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR